ANDELYN BIOSCIENCES
Live / Allowed — Notice of allowance issued (as of 28 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99032830
- Mark type
- Design + words
- Filed
- 07 Feb 2025
- Published for opposition
- 02 Sept 2025
- Attorney of record
- Ajay Jagtiani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders
Owner
- Andelyn Biosciences, Inc., Columbus, OH, US
- Andelyn Biosciences, Inc., Columbus, OH, US
Prosecution history
- 21 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 28 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 21 Jul 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 21 Jul 2025 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 21 Jul 2025 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 16 Jul 2025 — ASSIGNED TO EXAMINER
- 09 Jul 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED